Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Full Prescribing Information, Copaxone (glatiramer acetate)
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Avonex drug warning letter, severe hypatic injury
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Alpha/beta interferon is a neuronal growth factor.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Betaseron (Interferon Beta-1b) for SC Injection
Understanding the Role of T Cells in CNS Homeostasis.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.

Pages